Search

everythinglearnresearchcommunity

for

Search:↓

About 40% of women by age 60 experience significant hair loss, often due to androgenetic alopecia, with treatments like minoxidil available and hope for future cures.

The conclusion is that Treg-targeted therapies have potential, but more knowledge of Treg biology is needed for effective treatments, including for cancer.

Chronic Telogen Effluvium is a hair loss condition in middle-aged women that usually doesn't lead to complete baldness.

Tofacitinib was effective in treating hair loss in two patients with alopecia universalis.

Different treatments for alopecia areata have varying success rates and side effects; intralesional steroids are most effective.

Testosterone and dihydrotestosterone affect hair growth, and new techniques like the folliculogram help study it, but fully understanding hair growth is still complex.

Hair problems are common and distressing for women, but increasing knowledge of treatments offers hope.

The document concludes that there are various treatments for different types of alopecia, but more research is needed for evidence-based treatments.

The conclusion is that accurately identifying the cause of high androgen levels in women with PCOS is crucial and requires specific tests.

Surgeons suggested a standard system for hair transplant methods to improve communication and results.

Certain defective glucocorticoid receptor mutants move faster inside cell nuclei and work less effectively.

Wounds heal without scarring in early development but later result in scars, and studying Wnt signaling could help control scarring.

Corticosteroids may effectively regrow hair in Alopecia Totalis with manageable side effects.

Long COVID patients may have hormonal imbalances linked to their symptoms.

Different hormones affect hair growth and conditions, with some causing hair loss and others promoting it.

Alternative medicine lacks scientific support and relies on the placebo effect, but remains popular and integrated into German healthcare.

Detailed patient history and physical exams are crucial for diagnosing hair loss.

Most women in the study lost hair due to chronic shedding, with stress and nutrient deficiencies being common factors.

The cause of alopecia areata is likely a mix of genetics, immune system issues, and environmental factors, with more research needed to understand it fully.

A woman with severe angioedema improved significantly after treatment with rituximab.

The document concludes that treating female hair loss should target reducing excess androgen and blocking its effects on hair follicles, with the best treatments being hormonal therapy, adrenal suppression, and topical minoxidil.

Certain factors like allergies, nail problems, and hair loss patterns can predict how well someone with patchy hair loss will respond to skin cream treatments.

Skin changes can indicate hormonal imbalances and help diagnose endocrine disorders.

Mirex seems to promote a unique group of skin cells different from those affected by another tumor promoter, TPA.

Skin abnormalities can indicate immunodeficiency due to shared origins with the immune system.

A woman was the first known case to have both polycystic ovary syndrome and autoimmune polyglandular syndrome type 2, suggesting a need to check for both conditions in similar patients.

Topical minoxidil is the most promising treatment for male pattern hair loss, but more research is needed to confirm its effectiveness and safety.

The document concludes that parathyroid diseases have a range of clinical features and outcomes, with some conditions being treatable and others having a high risk of mortality.

The study concluded that a protein important for hair strength is regulated by certain molecular processes and is affected by growth phases.

The study developed a method to detect minoxidil and its sulfate form, found that minoxidil sulfate is temperature-sensitive, and identified a way to potentially increase its stability for hair loss treatment.